Intra-Cellular Therapies
ITCI
#1748
Rank
โ‚น816.60 B
Marketcap
โ‚น7,703
Share price
0.86%
Change (1 day)
72.73%
Change (1 year)

Earnings for Intra-Cellular Therapies (ITCI)

Earnings in 2024 (TTM): -โ‚น7.11 Billion

According to Intra-Cellular Therapies's latest financial reports the company's current earnings are โ‚น0.61 Billion. In 2023 the company made an earning of -โ‚น11.74 Billion, an increase over its 2022 earnings that were of -โ‚น21.63 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Intra-Cellular Therapies from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น7.11 Billion-39.45%
2023 -โ‚น11.74 Billion-45.74%
2022 -โ‚น21.63 Billion-9.81%
2021 -โ‚น23.98 Billion25.17%
2020 -โ‚น19.16 Billion53.66%
2019 -โ‚น12.47 Billion-4.77%
2018 -โ‚น13.09 Billion56.96%
2017 -โ‚น8.34 Billion-14.33%
2016 -โ‚น9.74 Billion10.09%
2015 -โ‚น8.85 Billion241.45%
2014 -โ‚น2.59 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น0.69 Billion-90.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น3.94 Billion-45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น14.66 Billion 104.06%๐Ÿ‡บ๐Ÿ‡ธ USA